Keratoconus treatment encompasses modern diagnostic and therapeutic methods aimed at controlling a progressive eye disease where the cornea gradually thins and bulges forward into a cone shape over time, and at preserving vision quality. The cornea is the transparent layer located at the very front of the eye, which ensures light is correctly focused onto the retina. The thinning of this structure and its loss of normal spherical shape can lead to irregular light refraction, significantly impairing vision quality.
Keratoconus typically begins in adolescence or young adulthood and can progress over years. When the disease is detected early, its progression can be halted or slowed down with appropriate treatment methods. Thanks to advanced imaging systems and modern treatment options available today, vision quality can be preserved in many patients, and the need for more advanced surgical procedures can be reduced.
The treatment plan is determined individually based on the stage of the disease, the degree of corneal thinning, vision level, and the patient's life expectations.
Keratoconus is a progressive corneal disease characterized by the thinning of the cornea and its bulging forward in a cone shape, resulting from the loss of its structural integrity.
Due to this deformation on the corneal surface, light entering the eye cannot be focused properly. As a result, blurred vision, irregular astigmatism, and a significant decrease in vision quality occur.
The disease mostly affects both eyes, but it may not progress with the same severity in both. One eye might be in a more advanced stage than the other.
The exact cause of keratoconus is not fully known. However, it is thought that genetic predisposition and environmental factors play a combined role.
Factors that may be effective in the development of the disease include:
Especially in individuals who constantly rub their eyes due to allergies, the risk of disease progression may increase. Therefore, stopping the habit of eye rubbing is an important part of the treatment.
The symptoms of keratoconus can vary depending on the stage of the disease.
The most common symptoms include:
As the disease progresses, it may become difficult to achieve sufficient vision with conventional eyeglasses.
Early diagnosis is one of the most important factors directly affecting the success of treatment.
The main methods used in the diagnosis of keratoconus are:
Especially corneal topography and tomography are of great importance in detecting the disease in its early stages.
The primary goal in keratoconus treatment is not solely to improve vision.
The main objectives of treatment are:
The same treatment method is not applied to every patient. Different options are evaluated based on the stage of the disease.
In patients with early-stage keratoconus, eyeglasses may be sufficient.
As the disease progresses and irregular astigmatism increases, achieving clear vision with conventional eyeglasses may become difficult.
In this case, special contact lenses are preferred.
Among the lenses that can be used are:
These lenses can provide better vision quality by optically compensating for the irregularity on the corneal surface.
Cross-Linking is one of the most effective treatment methods for halting the progression of keratoconus today.
During the procedure, riboflavin (vitamin B2) drops are applied to the cornea, and then the corneal collagen fibers are strengthened using controlled ultraviolet-A (UV-A) light.
This increases the biomechanical strength of the cornea, and the progression of the disease can be significantly slowed down or halted.
Cross-Linking yields very successful results, especially when applied in the early stages in young patients.
In some patients, the corneal shape can be reshaped with special ring segments implanted within the cornea.
This treatment aims to:
Not every keratoconus patient may be suitable for this method.
In suitable patients, excimer laser applications can be planned in combination with Cross-Linking.
These combination treatments can contribute to correcting the corneal shape.
However, laser treatment may not be suitable for severely thinned corneas.
The treatment plan is entirely formulated based on individual assessment.
In advanced-stage keratoconus patients where other treatments are insufficient, corneal transplantation may be considered.
Corneal transplantation can be performed as:
Today, thanks to early diagnosis and Cross-Linking, the number of patients requiring corneal transplantation has significantly decreased compared to previous years.
Since keratoconus is a chronic and progressive disease, regular check-ups after treatment are of great importance.
During check-ups:
Especially in young patients, more frequent follow-up may be recommended in the initial years.
Thanks to early diagnosis, protective treatments like Cross-Linking can be applied before the disease progresses.
This contributes significantly to:
Regular eye examinations and corneal analyses are of great importance, especially for individuals with a family history of keratoconus.
In keratoconus treatment, not only medical interventions but also the patient's daily habits are important.
Patients are generally given the following recommendations:
Keratoconus is a chronic disease. Treatments applied today aim to halt or slow down the progression of the disease.
No. Cross-Linking aims to stop progression by strengthening the cornea, but it does not completely eliminate the existing deformation.
With early diagnosis and appropriate treatment, severe vision loss can largely be prevented. In untreated advanced cases, vision can significantly decrease.
Genetic predisposition is one of the important risk factors. Individuals with a family history are recommended to have regular eye examinations.
In early stages, successful results can be achieved with methods such as eyeglasses, special contact lenses, and Cross-Linking. Not every patient requires surgical treatment.